Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2PArticle Published on 2022-11-012022-11-15 Journal: The Journal of Infectious Diseases [Category] [DOI] 10.1093/infdis/jiac153 PMC 바로가기
Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screeningArticle Published on 2022-11-012022-11-15 Journal: Virus research [Category] [DOI] 10.1016/j.virusres.2022.198915 PMC 바로가기
The kinetics of IgG subclasses and contributions to neutralizing activity against SARS-CoV-2 wild-type strain and variants in healthy adults immunized with inactivated vaccineArticle Published on 2022-10-012022-11-15 Journal: Immunology [Category] [DOI] 10.1111/imm.13531 PMC 바로가기
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipientsArticle Published on 2022-09-152022-11-15 Journal: Trials [Category] [DOI] 10.1186/s13063-022-06634-w PMC 바로가기
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screenArticle Published on 2022-09-072022-11-15 Journal: Molecular therapy : the journal of the American So [Category] [DOI] 10.1016/j.ymthe.2022.04.025 PMC 바로가기
A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adultsArticle Published on 2022-09-012022-11-15 Journal: Clinical and Translational Medicine [Category] [DOI] 10.1002/ctm2.1016 PMC 바로가기
Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort studyArticle Published on 2022-08-122022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.939311 PMC 바로가기
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trialRandomized Controlled Trial Published on 2022-08-012022-10-05 Journal: The Lancet. Respiratory Medicine [Category] [DOI] 10.1016/S2213-2600(22)00087-X PMC 바로가기 [Article Type] Randomized Controlled Trial
Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathologySARS-CoV-2에 의한 Gasdermin-D 활성화는 NET을 유발하고 COVID-19 면역병리를 매개합니다Article Published on 2022-07-072022-09-11 Journal: Critical Care [Category] [DOI] 10.1186/s13054-022-04062-5 PMC 바로가기 [Article Type] Article
Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine Research Published on 2022-07-042022-10-05 Journal: Nature biomedical engineering [Category] [DOI] 10.1038/s41551-022-00902-5 [Article Type] Research